Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer

Detalles Bibliográficos
Autores principales: Song, Wei, Tang, Lin, Xu, Yumei, Xu, Jing, Zhang, Wenwen, Xie, Hui, Wang, Shui, Guan, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353734/
https://www.ncbi.nlm.nih.gov/pubmed/28300203
http://dx.doi.org/10.1038/srep44346
_version_ 1782515182683029504
author Song, Wei
Tang, Lin
Xu, Yumei
Xu, Jing
Zhang, Wenwen
Xie, Hui
Wang, Shui
Guan, Xiaoxiang
author_facet Song, Wei
Tang, Lin
Xu, Yumei
Xu, Jing
Zhang, Wenwen
Xie, Hui
Wang, Shui
Guan, Xiaoxiang
author_sort Song, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-5353734
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53537342017-03-22 Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer Song, Wei Tang, Lin Xu, Yumei Xu, Jing Zhang, Wenwen Xie, Hui Wang, Shui Guan, Xiaoxiang Sci Rep Corrigenda Nature Publishing Group 2017-03-16 /pmc/articles/PMC5353734/ /pubmed/28300203 http://dx.doi.org/10.1038/srep44346 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigenda
Song, Wei
Tang, Lin
Xu, Yumei
Xu, Jing
Zhang, Wenwen
Xie, Hui
Wang, Shui
Guan, Xiaoxiang
Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title_full Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title_fullStr Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title_full_unstemmed Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title_short Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
title_sort corrigendum: parp inhibitor increases chemosensitivity by upregulating mir-664b-5p in brca1-mutated triple-negative breast cancer
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353734/
https://www.ncbi.nlm.nih.gov/pubmed/28300203
http://dx.doi.org/10.1038/srep44346
work_keys_str_mv AT songwei corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT tanglin corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT xuyumei corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT xujing corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT zhangwenwen corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT xiehui corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT wangshui corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer
AT guanxiaoxiang corrigendumparpinhibitorincreaseschemosensitivitybyupregulatingmir664b5pinbrca1mutatedtriplenegativebreastcancer

Ejemplares similares